News
Sherlock Biosciences in the News
Read about Sherlock’s work to revolutionize molecular diagnostics and bring highly accurate, rapid, and affordable testing to the world.
Media Inquiries
sherlockbio@consortpartners.com
February 21, 2023
Sherlock at Apex of CRISPR-based Diagnostics after USPTO Grants Earliest Priority Patent
February 01, 2023
Sherlock Biosciences Acquires Sense Biodetection Advancing CRISPR-Based Diagnostics for Consumers
November 29, 2022
Sherlock Biosciences Receives Grant to Advance Development of Power-free Diagnostics
November 01, 2022
Sherlock Biosciences and Tolo Biotech Expand Collaboration to Advance Development and Adoption of CRISPR-based Diagnostics
September 26, 2022
Sherlock Biosciences Named PM360 Trailblazer 2022 Company of the Year for Medical Device/Diagnostics